Skip to main content

Table 3 Antibiotic resistance and association with antibiotic use for E. coli

From: Intra-hospital differences in antibiotic use correlate with antimicrobial resistance rate in Escherichia coli and Klebsiella pneumoniae: a retrospective observational study

 

Resistance

Association with antibiotic use

No. of tests/strata

Proportion resistant (95% CI)

Odds ratio (95% CI)

p-value

Amoxicillin/Ampicillin

2330 / 139

62 (55–69)

1.08 (0.84–1.40)

0.53

Amoxicillin-clavulanic acid

2330 / 139

39 (35–44)

1.07 (1.02–1.12)

0.004

Ceftriaxone

1085 / 119

18 (13–24)

1.10 (0.68–1.76)

0.71

Cefepime

1083 / 119

8 (6–12)

1.06 (0.90–1.25)

0.49

Piperacillin-tazobactam

1085 / 119

17 (13–21)

2.11 (1.45–3.07)

< 0.001

Quinolones

2330 / 139

20 (17–23)

1.52 (1.25–1.86)

< 0.001

Trimethoprim-sulfamethoxazole

2329 / 139

32 (27–37)

1.59 (1.19–2.13)

0.002

Gentamicin

1085 / 119

18 (14–22)

1.30 (0.45–3.71)

0.63

Combined

13,657 / 1032

24 (15–36)

1.09 (1.04–1.14)

< 0.001

  1. Results from logistic mixed models for antibiotic resistance in relation to consumption. Odds ratios represent the change in the odds for resistance per increase in antibiotic use by 5 DDD/100 bed-days. Strata refer to year/department combinations
  2. CI confidence interval